ARTICLE | Company News
Xencor, Boehringer Ingelheim deal
October 18, 2010 7:00 AM UTC
Xencor received an undisclosed milestone payment from Boehringer under a 2007 deal in which Boehringer is using Xencor's XmAb technology to optimize an undisclosed antibody drug candidate. The milesto...